Search research articles
Contact Us
Filters
Showing results (391-400 of 396) with videos related to
Page
of 40
Sort By:
You have reached the last page of results.
This site can display upto 396 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157
Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Mabs
|
March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 20, 2018
Influence of alcoholism and cholesterol on TSPO binding in brain: PET [<sup>11</sup>C]PBR28 studies in humans and rodents
Sung Won Kim, Corinde E Wiers, Ryan Tyler, et al.
Science Advances
|
April 10, 2021
Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents
Corinde E Wiers, Leandro F Vendruscolo, Jan-Willem van der Veen, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Leo Zhang, Krystle Nomie, Hui Zhang, et al.
Page
of 40
Search research articles
Search
Showing results (391-400 of 396) with videos related to
Sort By:
Page
of 40
You have reached the last page of results.
This site can display upto 396 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157
Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Mabs
|
March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 20, 2018
Influence of alcoholism and cholesterol on TSPO binding in brain: PET [<sup>11</sup>C]PBR28 studies in humans and rodents
Sung Won Kim, Corinde E Wiers, Ryan Tyler, et al.
Science Advances
|
April 10, 2021
Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents
Corinde E Wiers, Leandro F Vendruscolo, Jan-Willem van der Veen, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy
Leo Zhang, Krystle Nomie, Hui Zhang, et al.
Page
of 40